Author | Yeara | Country | Design | Population (n) | Exposure assessment | Type of exposure | Associationb |
---|---|---|---|---|---|---|---|
Hyperthyroidism | |||||||
 Dekkers et al. [41] | 2017 | Denmark | Cohort | 932,913 | Hospital diagnoses | Unspecified | ↑ |
 Segna et al. [42] | 2016 | Schwitzerland | Cohort | 561 | Biochemical | Subclinical | ↓ |
 Zöller et al. [43] | 2012 | Sweden | Cohort | 535,538 | Hospital diagnoses | Unspecified | ↑ |
 Ramagopalan et al. [44] | 2011 | United Kingdom | Cohort | 4,310,042 | Hospital diagnoses | Unspecified | ↑ |
 Lin et al. [45] | 2010 | Taiwan | Case-cohort | 53,418 | Hospital diagnoses | Unspecified | ↑ |
 Danescu et al. [46] | 2009 | United States | Cohort | 908,805,000 | Hospital diagnoses | Unspecified | – |
 Squizzato et al. [47] | 2007 | Italy | Cross-sectional | 150 | Biochemical | Overt and subclinical | – |
Hypothyroidism | |||||||
 Segna et al. [42] | 2016 | Schwitzerland | Cohort | 561 | Biochemical | Subclinical | – |
 Zöller et al. [43] | 2012 | Sweden | Cohort | 535,538 | Hospital diagnoses | Unspecified | ↑ |
 Ramagopalan et al. [44] | 2011 | United Kingdom | Cohort | 4,869,188 | Hospital diagnoses | Unspecified | ↑ |
 Danescu et al. [46] | 2009 | United States | Cohort | 928,324,000 | Hospital diagnoses | Unspecified | ↑ |
 Squizzato et al. [47] | 2007 | Italy | Cross-sectional | 150 | Biochemical | Overt and subclinical | ↑ |
Thyroid homone levels | |||||||
 Lerstad et el [48]. | 2015 | Norway | Cohort | 11,962 | Biochemical | TSH | ↑ |
 Debeij et al. [49] | 2014 | Netherlands | Case-control | 5003 | Biochemical | TSH and free T4 | ↑ |
 Debeij et al. [50] | 2012 | Norway | Cohort | 1991 | Biochemical | TSH and free T4 | ↑ |
 van Zaane et al. [51] | 2009 | Netherlands | Case-control | 569 | Biochemical | TSH, free T4, total T3 | ↑ |